Tivozanib Bests Sorafenib in Metastatic Renal Cell Carcinoma
Progression-free survival longer in those receiving tivozanib as third- or fourth-line therapy
Aspirin May No Longer Have Effect in Primary CVD Prevention
Also no significant decrease seen in cancer death in studies from 2005 onward
Vitamin D Supplementation Offers No Benefit for Critically Ill
Among critically ill patients with vitamin D deficiency, supplementation did not improve 90-day mortality
Number of Teens Vaping Marijuana on the Rise
Two studies show increasing self-reported use among both middle and high school students
Enrollment in Affordable Care Act Holds Steady for Third Straight Year
However, fate of the program remains uncertain
Vaccination Rates Improved With Removal of Nonmedical Exemptions
In California, MMR coverage increased in postpolicy period, while nonmedical exemptions decreased
Gabapentinoids, Opioids Combo Carries Risk for Breathing Problems
Serious breathing problems can occur in patients who use gabapentinoids with opioids or other CNS depressants
Continuing Full Induction Regimen Not Beneficial in Metastatic CRC
Maintenance therapy shows benefit versus observation in terms of PFS but not overall survival
Anifrolumab Improves Response at 52 Weeks in Lupus
Rate of composite response showing reduced disease activity higher with anifrolumab versus placebo
FDA Gives First Ebola Vaccine for Adults the Green Light
Ervebo shown to be highly effective in preventing infection in people exposed to the virus
